Impact of COVID-19 on social prescribing across an Integrated Care System: A Researcher in Residence study.

COVID-19 Integrated Care Systems link worker primary care researcher-in-residence social prescribing

Journal

Health & social care in the community
ISSN: 1365-2524
Titre abrégé: Health Soc Care Community
Pays: England
ID NLM: 9306359

Informations de publication

Date de publication:
11 2022
Historique:
revised: 25 01 2022
received: 02 11 2021
accepted: 02 03 2022
pubmed: 1 4 2022
medline: 20 12 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Emerging evidence suggests that connecting people to non-medical activities in the community (social prescribing) may relieve pressure on services by promoting autonomy and resilience, thereby improving well-being and self-management of health. This way of working has a long history in the voluntary and community sector but has only recently been widely funded by the National Health Service (NHS) in England and implemented in Primary Care Networks (PCNs). The COVID-19 global pandemic coincided with this new service. There is wide variation in how social prescribing is implemented and scant evidence comparing different delivery models. As embedded researchers within an Integrated Care System in the Southwest of England, we examined the impact of COVID on the implementation of social prescribing in different employing organisations during the period March 2020 to April 2021. Data were collected from observations and field notes recorded during virtual interactions with over 80 social prescribing practitioners and an online survey of 52 social prescribing practitioners and middle managers. We conceptualise social prescribing as a pathway comprising access, engagement and activities, facilitated by workforce and community assets and strategic partnerships. We found that these elements were all impacted by the pandemic, but to different degrees according to the way the service was contracted, whether referrals (access) and approach (engagement) were universal ('open') or targeted ('boundaried') and the extent to which practitioners' roles were protected or shifted towards immediate COVID-specific work. Social prescribers contracted in PCNs were more likely to operate an 'open' model, although boundaries were developing over time. We suggest the presence of an explicit, agreed delivery model (whether 'open' or 'boundaried') might create a more coherent approach less likely to result in practitioner role drift, whilst allowing flexibility to adjust to the pandemic and enhancing practitioner satisfaction and well-being. The potential consequences of different models are examined.

Identifiants

pubmed: 35355347
doi: 10.1111/hsc.13802
pmc: PMC9111657
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4086-e4094

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Health and Social Care in the Community published by John Wiley & Sons Ltd.

Références

Bertotti, M., Frostick, C., Hutt, P., Sohanpal, R., & Carnes, D. (2018). A realist evaluation of social prescribing: An exploration into the context and mechanisms underpinning a pathway linking primary care with the voluntary sector. Primary Health Care Research & Development, 19(3), 232-245. https://doi.org/10.1017/S1463423617000706
Bhatti, S., Rayner, J., Pinto, A. D., Mulligan, K., & Cole, D. C. (2021). Using self-determination theory to understand the social prescribing process: A qualitative study. BJGP Open, 5(2). https://doi.org/10.3399/bjgpo.2020.0153
Calderón-Larrañaga, S., Milner, Y., Clinch, M., Greenhalgh, T., & Finer, S. (2021). Tensions and opportunities in social prescribing. Developing a framework to facilitate its implementation and evaluation in primary care: A realist review. BJGP Open, 5(3), BJGPO.2021.0017. https://doi.org/10.3399/BJGPO.2021.0017
Creswell, J. W., & Plano Clark, V. L. (2011). Designing and conducting mixed methods research (2nd ed.). SAGE Publications.
Dayson, C. (2017). Policy commentary-Social prescribing ‘plus’: A model of asset-based collaborative innovation? People, Place and Policy, 11(2), 90-104. https://doi.org/10.3351/ppp.2017.4839587343
Department Health and Social Care, PHE, & NHSE. (2016). Independent report: Review of partnerships and investment in the voluntary sector-How voluntary, community and social enterprise (VCSE) organisations contribute to wellbeing, health and care. https://www.gov.uk/government/publications/review-of-partnerships-and-investment-in-the-voluntary-sector
Drinkwater, C., Wildman, J., & Moffatt, S. (2019). Social prescribing. BMJ, 364, l1285. https://doi.org/10.1136/bmj.l1285
Fixsen, A., Barrett, S., & Shimonovich, M. (2021). Weathering the storm: A qualitative study of social prescribing in urban and rural Scotland during the COVID-19 pandemic. SAGE Open Medicine, 9, 20503121211029187. https://doi.org/10.1177/20503121211029187
Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13(1), 117. https://doi.org/10.1186/1471-2288-13-117
Gibson, K., Pollard, T. M., & Moffatt, S. (2021). Social prescribing and classed inequality: A journey of upward health mobility? Social Science & Medicine, 280, 114037. https://doi.org/10.1016/j.socscimed.2021.114037
Gradinger, F., Elston, J., Asthana, S., Martin, S., & Byng, R. (2019). Reflections on the Researcher-in-Residence model co-producing knowledge for action in an Integrated Care Organisation: A mixed methods case study using an impact survey and field notes. Evidence & Policy: A Journal of Research, Debate and Practice, 15(2), 197-215. https://doi.org/10.1332/174426419X15538508969850
Guest, G., & Fleming, P. (2015). Mixed methods research. In G. Guest, & E. E. Namey (Eds.), Public health research methods (pp. 581-610). Sage.
Hazeldine, E., Gowan, G., Wigglesworth, R., Pollard, J., Asthana, S., & Husk, K. (2021). Link worker perspectives of early implementation of social prescribing: A ‘Researcher-in-Residence’ study. Health and Social Care in the Community, 29(6), 1844-1851. https://doi.org/10.1111/hsc.13295
Husk, K., Blockley, K., Lovell, R., Bethel, A., Lang, I., Byng, R., & Garside, R. (2020). What approaches to social prescribing work, for whom, and in what circumstances? A realist review. Health & Social Care in the Community, 28(2), 309-324. https://doi.org/10.1111/hsc.12839
Kimberlee, R. (2015). What is social prescribing? Advances in Social Sciences Research Journal, 2. https://doi.org/10.14738/assrj.21.808
Manion, L. (2020-2021). Summary feedback from Devon Engagement Service Partners/Service Users regarding COVID 19. Devon County Council.
Munford, L. A., Wilding, A., Bower, P., & Sutton, M. (2020). Effects of participating in community assets on quality of life and costs of care: Longitudinal cohort study of older people in England. British Medical Journal Open, 10(2), e033186. https://doi.org/10.1136/bmjopen-2019-033186
National Council for Voluntary Organisations. (2020). The Impact of a second lockdown on the voluntary sector: Briefing to MPs. https://www.ncvo.org.uk/images/documents/about_us/media-centre/MP_briefing.pdf
NHS digital. (2020). COVID-19 - high risk shielded patient list identification methodology. https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology
NHS England. (2018). The NHS long term plan.
NHS England. (2019). The conclusions of the joint Voluntary Community and Social Enterprise review. https://vcsereview.org.uk/2019/06/26/the-conclusions-of-the-joint-voluntary-community-social-enterprise-review/
NHS England. (2019). Primary care networks. https://www.england.nhs.uk/primary-care/primary-care-networks/
NHS England. (2019c). Universal personalised care: implementing the comprehensive model. https://www.england.nhs.uk/wp-content/uploads/2019/01/universal-personalised-care.pdf
NHS England. (2021). Investment and Impact Fund 2020/21. https://www.england.nhs.uk/publication/investment-and-impact-fund-2020-21/
Norman, C., Wildman, J. M., & Sowden, S. (2021). COVID-19 at the deep end: A qualitative interview study of primary care staff working in the most deprived areas of England during the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 18(16), 8689. https://doi.org/10.3390/ijerph18168689
O’Dowd, A. (2020). Primary care networks: More effort is needed to engage with general practices, says report. BMJ, 371, m4551. https://doi.org/10.1136/bmj.m4551
Ogden, J. (2020). Social prescribing in a time of Covid-19 and social isolation. Progress in Neurology and Psychiatry, 24(3), 4-5. https://doi.org/10.1002/pnp.670
Pescheny, J. V., Pappas, Y., & Randhawa, G. (2018). Facilitators and barriers of implementing and delivering social prescribing services: A systematic review. BMC Health Services Research, 18(1), 86. https://doi.org/10.1186/s12913-018-2893-4
Polley, M., Fleming, J., Anfilogoff, T., & Carpenter, A. (2017). Making sense of social prescribing.
Ritchie, J., & Lewis, J. (2003). Qualitative research practice: A guide for social science students. SAGE.
South, J., Bagnall, A.-M., Stansfield, J. A., Southby, K. J., & Mehta, P. (2019). An evidence-based framework on community-centred approaches for health: England, UK. Health Promotion International, 34(2), 356-366. https://doi.org/10.1093/heapro/dax083
Tierney, S. (2020). Can social prescribing support the COVID-19 pandemic? https://www.cebm.net/covid-19/can-social-prescribing-support-the-covid-19-pandemic/
Tierney, S., Wong, G., Roberts, N., Boylan, A.-M., Park, S., Abrams, R., Reeve, J., Williams, V., & Mahtani, K. R. (2020). Supporting social prescribing in primary care by linking people to local assets: A realist review. BMC Medicine, 18(1), 49. https://doi.org/10.1186/s12916-020-1510-7
Vidovic, D., Reinhardt, G. Y., & Hammerton, C. (2021). Can social prescribing foster individual and community well-being? A systematic review of the evidence. International Journal of Environmental Research and Public Health, 18(10). https://doi.org/10.3390/ijerph18105276
Westlake, D., Elston, J., Gude, A., Gradinger, F., Husk, K., & Asthana, A. (2021). Devon integrated care system, exeter. https://www.plymouth.ac.uk/uploads/production/document/path/21/21183/DESSPER_-_Impact_of_Covid_19_on_Social_Prescribing_in_Devon_Final_report_v2_190821_notes_pagespdf
Wildman, J. M., Moffatt, S., Penn, L., O'Brien, N., Steer, M., & Hill, C. (2019). Link workers’ perspectives on factors enabling and preventing client engagement with social prescribing. Health & Social Care in the Community, 27(4), 991-998. https://doi.org/10.1111/hsc.12716
Younan, H. C., Junghans, C., Harris, M., Majeed, A., & Gnani, S. (2020). Maximising the impact of social prescribing on population health in the era of COVID-19. Journal of the Royal Society of Medicine, 113(10), 377-382. https://doi.org/10.1177/0141076820947057

Auteurs

Debra Westlake (D)

Community and Primary Care Research Group, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK.
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK.

Julian Elston (J)

Community and Primary Care Research Group, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK.

Alex Gude (A)

Community and Primary Care Research Group, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK.

Felix Gradinger (F)

Community and Primary Care Research Group, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK.

Kerryn Husk (K)

Applied Research Collaboration South West Peninsula (PenARC), Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth, National Institute for Health Research, Plymouth, UK.

Sheena Asthana (S)

Plymouth Institute of Health and Care Research, Plymouth, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH